Bupropion Hydrochloride
Product Images NDC 51407-207

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 51407-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1407 206 30lb

1407 206 30lb
This is a description of a medication called Bupropion Hydrochloride Extended-Release Tablets (XL) manufactured by TWi Pharmaceutical, Inc. and packaged by GSMS, Incorporated. Each tablet contains 150 mg of bupropion HCl and is intended to be taken once daily or as directed by a physician. It is advised to protect the medication from light and to store it at a temperature between 20°C to 25°C. The packaging of this medication includes a medication guide that should be given to each patient by the pharmacist. The medication should not be used along with other medicines containing bupropion HCl.*
FDA Label Image

51407-207-05lb (BUPROPION HCl 300 MG ER.jpg)

51407-207-05lb (BUPROPION HCl 300 MG ER.jpg)
This text is a description of a medication called "bupropion Hydrochloride" in the form of extended-release tablets. The tablets are packaged in a container of 500 tablets each containing 300 mg of the active ingredient. The medication is intended to be taken daily as directed by a physician, and a medication guide should be dispensed to each patient by the pharmacist. The medication should be stored in a controlled room temperature of 20°C to 25°C and protected from light. The manufacturer of the medication is TWi Pharmaceutical, Inc. located in Taoyuan City, Taiwan, and the medication is packaged by GSMS, Incorporated located in Camarillo, CA, USA. This medication should not be used in combination with Zyban or any other medicines containing bupropion hydrochloride.*
FDA Label Image

Image Description (Bupropion Hydrochloride Sr 1)

FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.